somatostatin receptor subtype 5 antagonists (SCOHIA PHARMA/Takeda Pharmaceutical)

N/A

Report date: 2025/03/20 09:24:12
NME

Base Information

Drug Namesomatostatin receptor subtype 5 antagonists (SCOHIA PHARMA/Takeda Pharmaceutical)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSomatostatin receptor 5 antagonists
TargetsSomatostatin receptor 5
Therapy Area/IndicationsDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTakeda Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesTakeda Pharmaceutical Co LtdScohia Pharma Inc
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 2
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A